רקויפ מודוטאב 2 מ"ג - Requip modutab 2 mg
× ×ª×× × ×ª×¨×פ×
×××¨×©× 
| ××× ×× ×× × ×ספ×× | ||||||
|---|---|---|---|---|---|---|
| ×§×××¦× ×¤×¨××§×××××ת (ATC4) | N04BC Dopamine agonists | |||||
| ×ר××× ×¤×¢×× (ATC5) | Â
| |||||
| צ×רת ××ª× | פ××× - PER OS | |||||
| צ×רת ××× ×× | ×××××ת ×צ×פ×ת פ××× - ש×ר×ר ×××ש×, FILM COATED TABLETS - PROLONGED RELEASE ××× ×עת ××× ×× ×תר ×× ×רע×× ×ש ××××× ×ת ×תר××¤× ××ת×× ×××× ×× ××××××¥ ××¤× ×©××פ××¢ ××¢××× ×צר×× | |||||
| ×ת×××× | Treatment of Parkinsonâs disease under the following conditions:⢠Initial treatment as monotherapy, in order to delay the introduction of levodopa⢠In combination with levodopa, over the course of the disease, when the effect of levodopa wears off or becomes inconsistent and fluctuations in the therapeutic effect occur (âend of doseâ or âon-offâ type fluctuations)." | |||||
× ×ª×× × ×¡× [ ×צ×× ]
| ||||||
| ×¢××× ×ר××¤× ××××ר×ת ××¢××× |
 Â
| |||||
| ×¢××× ×צר×× |  |
|---|
| ער××× ×××××§×רפ××× | ער××× ×§×©×ר×× ×××××§×רפ××× |
|---|---|
| רק×××פ ××××××× 2 ×"× ××××ר ××©×¨× ××ר×××ת |
| ××פ×ש ×××ר×× | ×××ר×× ×-PubMed |
|---|---|
| ××××¢ ×רשת | RxList WebMD Drugs.com |
| ×©× ××¦×¨× | GLAXO WELLCOME SA, SPAIN |
| ×©× ××¢× ×ר×ש×× | GLAXO SMITH KLINE (ISRAEL) LTD |
| ר×ש××× | ת×ר×× ××ש×: 10/2011. ר×ש××× ×ת×ר××: 08/2014 |
| ת×ר×× ×¢×××× ××ר×× | 15/05/19 |
ת××× ×ª ×ר×××